US4816570A
(en)
|
1982-11-30 |
1989-03-28 |
The Board Of Regents Of The University Of Texas System |
Biologically reversible phosphate and phosphonate protective groups
|
US4968788A
(en)
|
1986-04-04 |
1990-11-06 |
Board Of Regents, The University Of Texas System |
Biologically reversible phosphate and phosphonate protective gruops
|
ES2083580T3
(es)
|
1990-06-13 |
1996-04-16 |
Arnold Glazier |
Profarmacos de fosforo.
|
DE69129650T2
(de)
|
1990-09-14 |
1999-03-25 |
Acad Of Science Czech Republic |
Wirkstoffvorläufer von Phosphonaten
|
US6887707B2
(en)
|
1996-10-28 |
2005-05-03 |
University Of Washington |
Induction of viral mutation by incorporation of miscoding ribonucleoside analogs into viral RNA
|
HUP0100998A3
(en)
|
1998-03-03 |
2001-12-28 |
Novo Nordisk As |
(2e)-5-amino-5-methylhex-2-enoic acid n-methyl-n-((1r)-1-(n-methyl-n-((1r)-1-(methylcarbamoyl)-2-phenylethyl)carbamoyl)-2-(2-naphtyl)ethyl)amide salts, methods for their preparation, pharmaceutical compositions comprising thereof and their use
|
US6312662B1
(en)
|
1998-03-06 |
2001-11-06 |
Metabasis Therapeutics, Inc. |
Prodrugs phosphorus-containing compounds
|
WO1999049873A1
(en)
|
1998-03-27 |
1999-10-07 |
Regents Of The University Of Minnesota |
Nucleosides with antiviral and anticancer activity
|
CN1127186C
(zh)
|
1998-04-29 |
2003-11-05 |
中国科学院福建物质结构研究所 |
一种自锁模激光器
|
CN1147466C
(zh)
|
1998-05-28 |
2004-04-28 |
华中理工大学 |
一种酰胺类化合物及其制备方法和用途
|
AU760688B2
(en)
|
1998-10-16 |
2003-05-22 |
Merck Sharp & Dohme Limited |
Pyrazolo-triazine derivatives as ligands for GABA receptors
|
DE19912636A1
(de)
|
1999-03-20 |
2000-09-21 |
Aventis Cropscience Gmbh |
Bicyclische Heterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Herbizide und pharmazeutische Mittel
|
JP2003514766A
(ja)
|
1999-06-03 |
2003-04-22 |
アボット・ラボラトリーズ |
活性剤としてルイス酸を用いるオリゴヌクレオチド合成
|
AUPQ105499A0
(en)
|
1999-06-18 |
1999-07-08 |
Biota Scientific Management Pty Ltd |
Antiviral agents
|
US6656915B1
(en)
|
1999-09-15 |
2003-12-02 |
Biocryst Pharmaceuticals, Inc. |
Inhibiting T-cell proliferation
|
WO2001032153A2
(en)
|
1999-11-04 |
2001-05-10 |
Shire Biochem Inc. |
Method for the treatment or prevention of flaviviridae viral infection using nucleoside analogues
|
JP2003523978A
(ja)
|
2000-02-18 |
2003-08-12 |
シャイアー・バイオケム・インコーポレイテッド |
ヌクレオシドアナログを用いるflavivirus感染の処置もしくは予防するための方法
|
MY164523A
(en)
|
2000-05-23 |
2017-12-29 |
Univ Degli Studi Cagliari |
Methods and compositions for treating hepatitis c virus
|
ES2227203T3
(es)
|
2000-05-26 |
2005-04-01 |
Idenix (Cayman) Limited |
Metodos para tratar la infeccion por el virus de la hepatitis delta con beta-1-2'-desoxinucleosidos.
|
CN1315862C
(zh)
|
2000-05-26 |
2007-05-16 |
艾登尼科斯(开曼)有限公司 |
处理黄病毒和瘟病毒的方法和组合物
|
CN1291994C
(zh)
|
2000-07-21 |
2006-12-27 |
吉里德科学公司 |
核苷酸膦酸酯类似物前药及其筛选和制备方法
|
US20030008841A1
(en)
|
2000-08-30 |
2003-01-09 |
Rene Devos |
Anti-HCV nucleoside derivatives
|
CA2426187C
(en)
|
2000-10-18 |
2011-08-16 |
Pharmasset Limited |
Modified nucleosides for the treatment of viral infections and abnormal cellular proliferation
|
AUPR213700A0
(en)
|
2000-12-18 |
2001-01-25 |
Biota Scientific Management Pty Ltd |
Antiviral agents
|
SK286630B6
(sk)
|
2001-01-22 |
2009-02-05 |
Merck & Co., Inc. |
Nukleozidové deriváty, farmaceutický prostriedok s ich obsahom a ich použitie
|
DE10145223A1
(de)
|
2001-09-13 |
2003-04-03 |
Basf Ag |
Verfahren zur Herstellung von meso-Zeaxanthin
|
JP2005536440A
(ja)
|
2001-09-28 |
2005-12-02 |
イデニクス(ケイマン)リミテツド |
4’位が修飾されたヌクレオシドを使用するフラビウイルスおよびペスチウイルスの治療のための方法および組成物
|
AT410792B
(de)
|
2001-12-28 |
2003-07-25 |
Dsm Fine Chem Austria Gmbh |
Verfahren zur herstellung von geschützten, enantiomeren-angereicherten cyanhydrinen durch in-situ-derivatisierung
|
DE60213196T2
(de)
|
2002-02-13 |
2006-11-23 |
Matsushita Electric Industrial Co., Ltd., Kadoma |
Verfahren zum Übertragen von Datenpaketen unter Verwendung der Protokolle RTP und RTCP
|
JP2005525358A
(ja)
|
2002-02-28 |
2005-08-25 |
ビオタ インコーポレーティッド |
ヌクレオチド模倣体およびそのプロドラッグ
|
JP2005524662A
(ja)
|
2002-02-28 |
2005-08-18 |
ビオタ インコーポレーティッド |
ヌクレオシド5’−一リン酸模倣物およびこれらのプロドラッグ
|
US20040138170A1
(en)
|
2002-03-06 |
2004-07-15 |
Montgomery John A. |
Nucleosides, preparation thereof and use as inhibitors of rna viral polymerases
|
GB0210127D0
(en)
|
2002-05-02 |
2002-06-12 |
Merck Sharp & Dohme |
Therapeutic agents
|
GB0210124D0
(en)
|
2002-05-02 |
2002-06-12 |
Merck Sharp & Dohme |
Therapeutic agents
|
RU2004135392A
(ru)
|
2002-05-06 |
2005-06-27 |
Дженелэбс Текнолоджиз, Инк. (Us) |
Производные нуклеозидов для лечения инфекции, вызываемой вирусом гепатита с
|
AU2003233667A1
(en)
|
2002-05-23 |
2003-12-12 |
Biocryst Pharmaceuticals, Inc. |
Enhancing the efficacy of reverse transcriptase and dna polymerase inhibitors (nucleoside analogs) using pnp inhibitors and/or 2'-deoxyguanosine and/or prodrug thereof
|
CA2506129C
(en)
|
2002-11-15 |
2015-02-17 |
Idenix (Cayman) Limited |
2'-branched nucleosides and flaviviridae mutation
|
TWI332507B
(en)
|
2002-11-19 |
2010-11-01 |
Hoffmann La Roche |
Antiviral nucleoside derivatives
|
US7429565B2
(en)
|
2003-04-25 |
2008-09-30 |
Gilead Sciences, Inc. |
Antiviral phosphonate analogs
|
WO2004112687A2
(en)
|
2003-06-26 |
2004-12-29 |
Biotron Limited |
Antiviral acylguanidine compounds and methods
|
GB0317009D0
(en)
|
2003-07-21 |
2003-08-27 |
Univ Cardiff |
Chemical compounds
|
ES2351603T3
(es)
|
2003-07-25 |
2011-02-08 |
Idenix Pharmaceuticals, Inc. |
Análogos de nucleósidos de purina para el tratamiento de enfermedades causadas por flaviridae incluyendo hepatitis c.
|
CN1863813B
(zh)
|
2003-08-27 |
2011-03-30 |
生物区科学管理控股有限公司 |
作为治疗剂的三环核苷或核苷酸
|
JP2005187428A
(ja)
|
2003-12-26 |
2005-07-14 |
Univ Of Tokyo |
抗mgl抗体によるフィロウイルス治療薬
|
JP2005185235A
(ja)
|
2003-12-26 |
2005-07-14 |
Univ Of Tokyo |
ウイルス感染に対する感受性診断のための方法およびキット。
|
WO2005092877A1
(de)
|
2004-03-16 |
2005-10-06 |
Boehringer Ingelheim International Gmbh |
Glucopyranosyl-substituierte benzol-derivate, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung
|
EP1754768B1
(en)
|
2004-05-31 |
2011-03-30 |
DIC Corporation |
Polymerizable liquid crystal composition and optically anisotropic body
|
EP1758453B1
(en)
|
2004-06-15 |
2014-07-16 |
Merck Sharp & Dohme Corp. |
C-purine nucleoside analogs as inhibitors of rna-dependent rna viral polymerase
|
WO2006002231A1
(en)
|
2004-06-22 |
2006-01-05 |
Biocryst Pharmaceuticals, Inc. |
Aza nucleosides, preparation thereof and use as inhibitors of rna viral polymerases
|
EP3109244B1
(en)
|
2004-09-14 |
2019-03-06 |
Gilead Pharmasset LLC |
Preparation of 2'fluoro-2'-alkyl-substituted or other optionally substituted ribofuranosyl pyrimidines and purines and their derivatives
|
WO2006065335A2
(en)
|
2004-10-21 |
2006-06-22 |
Merck & Co., Inc. |
Fluorinated pyrrolo[2,3-d]pyrimidine nucleosides for the treatment of rna-dependent rna viral infection
|
US8133870B2
(en)
|
2004-10-29 |
2012-03-13 |
Biocryst Pharmaceuticals, Inc. |
Therapeutic furopyrimidines and thienopyrimidines
|
CA2587639A1
(en)
|
2004-12-16 |
2006-06-22 |
Boehringer Ingelheim International Gmbh |
Glucopyranosyl-substituted benzene derivatives, medicaments containing such compounds, their use and process for their manufacture
|
CN2778310Y
(zh)
|
2005-01-13 |
2006-05-10 |
中国人民解放军军事医学科学院野战输血研究所 |
心内膜注射导管
|
CA2600886A1
(en)
|
2005-03-08 |
2006-09-14 |
Biota Scientific Management Pty Ltd. |
Bicyclic nucleosides and nucleotides as therapeutic agents
|
EP2537520A1
(en)
|
2005-03-29 |
2012-12-26 |
Biocryst Pharmaceuticals, Inc. |
Hepatics C therapies
|
TW200720285A
(en)
|
2005-04-25 |
2007-06-01 |
Genelabs Tech Inc |
Nucleoside compounds for treating viral infections
|
WO2006121820A1
(en)
|
2005-05-05 |
2006-11-16 |
Valeant Research & Development |
Phosphoramidate prodrugs for treatment of viral infection
|
WO2007027248A2
(en)
|
2005-05-16 |
2007-03-08 |
Valeant Research & Development |
3', 5' - cyclic nucleoside analogues for treatment of hcv
|
NZ610715A
(en)
|
2005-06-24 |
2014-07-25 |
Biotron Ltd |
Antiviral compounds and methods
|
CN101321775B
(zh)
|
2005-10-03 |
2012-05-23 |
大学健康网络 |
用于治疗疟疾的odcase抑制剂
|
JP5116687B2
(ja)
|
2005-11-02 |
2013-01-09 |
バイエル・ファルマ・アクチェンゲゼルシャフト |
がんおよび他の過剰増殖性疾患の処置のためのピロロ[2,1−f][1,2,4]トリアジン−4−イルアミンIGF−1Rキナーゼ阻害剤
|
NO20055456L
(no)
|
2005-11-17 |
2007-05-18 |
Fluens Synthesis As |
Kontinuerlig stromningsreaktor
|
EP2133345A1
(en)
|
2005-12-01 |
2009-12-16 |
Basilea Pharmaceutica AG |
Process for the manufacture of epoxybutanol intermediates
|
WO2007064931A2
(en)
|
2005-12-02 |
2007-06-07 |
Bayer Healthcare Llc |
Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
|
PE20070855A1
(es)
|
2005-12-02 |
2007-10-14 |
Bayer Pharmaceuticals Corp |
Derivados de 4-amino-pirrolotriazina sustituida como inhibidores de quinasas
|
EP1957510A1
(en)
|
2005-12-09 |
2008-08-20 |
F.Hoffmann-La Roche Ag |
Antiviral nucleosides
|
EP1971331A2
(en)
|
2005-12-09 |
2008-09-24 |
Basilea Pharmaceutica AG |
4-oxo-(iso)tretinoin for the topical treatment of severe dermatological disorders
|
CA2637879A1
(en)
|
2006-02-14 |
2007-08-23 |
Merck & Co., Inc. |
Nucleoside aryl phosphoramidates for the treatment of rna-dependent rna viral infection
|
WO2007097991A2
(en)
|
2006-02-16 |
2007-08-30 |
Pharmasset, Inc. |
Methods and kits for dosing of antiviral agents
|
DE102006015378A1
(de)
|
2006-04-03 |
2007-10-04 |
Ludwig-Maximilians-Universität München |
Verfahren zur Synthese von Organoelementverbindungen
|
AR061024A1
(es)
|
2006-05-22 |
2008-07-30 |
Novartis Ag |
Maleato de 5-amino-3- (2'3'-di-o-acetil-beta-d-ribofuranosil)-3h-tiazolo[4,5-d] pirimidin-2-ona.
|
US7842672B2
(en)
|
2006-07-07 |
2010-11-30 |
Gilead Sciences, Inc. |
Phosphonate inhibitors of HCV
|
ATE499940T1
(de)
|
2006-07-18 |
2011-03-15 |
Anadys Pharmaceuticals Inc |
Carbonat- und carbamat-prodrugs von thiazolo ä4,5-dü-pyrimidinen
|
WO2008033466A2
(en)
|
2006-09-14 |
2008-03-20 |
Combinatorx (Singapore) Pre. Ltd. |
Compositions and methods for treatment of viral diseases
|
US7879806B2
(en)
|
2006-11-06 |
2011-02-01 |
Boehringer Ingelheim International Gmbh |
Glucopyranosyl-substituted benzyl-benzonitrile derivates, medicaments containing such compounds, their use and process for their manufacture
|
CA2672613A1
(en)
|
2006-12-20 |
2008-07-03 |
Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. |
Nucleoside cyclic phosphoramidates for the treatment of rna-dependent rna viral infection
|
US7951789B2
(en)
|
2006-12-28 |
2011-05-31 |
Idenix Pharmaceuticals, Inc. |
Compounds and pharmaceutical compositions for the treatment of viral infections
|
US8071568B2
(en)
|
2007-01-05 |
2011-12-06 |
Merck Sharp & Dohme Corp. |
Nucleoside aryl phosphoramidates for the treatment of RNA-dependent RNA viral infection
|
CN101611046A
(zh)
|
2007-01-12 |
2009-12-23 |
拜奥克里斯特制药公司 |
抗病毒的核苷类似物
|
CN101730699A
(zh)
|
2007-03-21 |
2010-06-09 |
百时美施贵宝公司 |
可用于治疗增殖性、变应性、自身免疫性和炎症性疾病的稠合杂环化合物
|
US7964580B2
(en)
|
2007-03-30 |
2011-06-21 |
Pharmasset, Inc. |
Nucleoside phosphoramidate prodrugs
|
AU2008251555B2
(en)
|
2007-05-10 |
2012-08-30 |
Biocryst Pharmaceuticals, Inc. |
Tetrahydrofuro [3 4-D] dioxolane compounds for use in the treatment of viral infections and cancer
|
CN100532388C
(zh)
|
2007-07-16 |
2009-08-26 |
郑州大学 |
2’-氟-4’-取代-核苷类似物、其制备方法及应用
|
NZ583652A
(en)
|
2007-08-03 |
2012-06-29 |
Biotron Ltd |
Hepatitis c antiviral compositions and methods
|
KR101502533B1
(ko)
|
2007-11-22 |
2015-03-13 |
에스케이케미칼주식회사 |
우수한 안정성을 갖는 택산 유도체 함유 주사제용동결건조 조성물 및 이의 제조방법
|
TW200942243A
(en)
|
2008-03-05 |
2009-10-16 |
Biocryst Pharm Inc |
Antiviral therapeutic agents
|
US8227431B2
(en)
|
2008-03-17 |
2012-07-24 |
Hetero Drugs Limited |
Nucleoside derivatives
|
US7863291B2
(en)
|
2008-04-23 |
2011-01-04 |
Bristol-Myers Squibb Company |
Quinuclidine compounds as alpha-7 nicotinic acetylcholine receptor ligands
|
KR101681559B1
(ko)
|
2008-04-23 |
2016-12-01 |
길리애드 사이언시즈, 인코포레이티드 |
항바이러스 치료를 위한 1'-치환된 카바-뉴클레오사이드 유사체
|
WO2010036407A2
(en)
|
2008-05-15 |
2010-04-01 |
Biocryst Pharmaceuticals, Inc. |
Antiviral nucleoside analogs
|
EP2313102A2
(en)
|
2008-07-03 |
2011-04-27 |
Biota Scientific Management |
Bycyclic nucleosides and nucleotides as therapeutic agents
|
AU2009298802A1
(en)
|
2008-09-23 |
2010-04-08 |
Alnylam Pharmaceuticals, Inc. |
Chemical modifications of monomers and oligonucleotides with cycloaddition
|
DK2396340T3
(en)
|
2009-02-10 |
2014-03-10 |
Gilead Sciences Inc |
Carbanucleosidanaloge to antiviral therapy
|
AR075584A1
(es)
|
2009-02-27 |
2011-04-20 |
Intermune Inc |
COMPOSICIONES TERAPEUTICAS QUE COMPRENDEN beta-D-2'-DESOXI-2'-FLUORO-2'-C-METILCITIDINA Y UN DERIVADO DE ACIDO ISOINDOL CARBOXILICO Y SUS USOS. COMPUESTO.
|
EA201190178A1
(ru)
|
2009-03-20 |
2012-06-29 |
Алиос Биофарма, Инк. |
Замещённые нуклеозидные и нуклеотидные аналоги
|
RU2489435C2
(ru)
|
2009-03-24 |
2013-08-10 |
Байокрист Фармасьютикалз, Инк. |
Полезные фармацевтические соли 7-[(3r,4r) -3-гидрокси-4- гидроксиметил- пирролидин -1- илметил ]- 3,5- дигидро-пирроло [ 3,2-d] пиримидин-4-она
|
TWI583692B
(zh)
|
2009-05-20 |
2017-05-21 |
基利法瑪席特有限責任公司 |
核苷磷醯胺
|
PE20120666A1
(es)
|
2009-07-21 |
2012-06-01 |
Gilead Sciences Inc |
Inhibidores de los virus flaviviridae
|
ES2730805T3
(es)
|
2009-09-21 |
2019-11-12 |
Gilead Sciences Inc |
Análogos de carba-nucleósido sustituido por 2'-fluoro para el tratamiento antiviral
|
US8455451B2
(en)
|
2009-09-21 |
2013-06-04 |
Gilead Sciences, Inc. |
2'-fluoro substituted carba-nucleoside analogs for antiviral treatment
|
WO2011035250A1
(en)
|
2009-09-21 |
2011-03-24 |
Gilead Sciences, Inc. |
Processes and intermediates for the preparation of 1'-substituted carba-nucleoside analogs
|
US7973013B2
(en)
|
2009-09-21 |
2011-07-05 |
Gilead Sciences, Inc. |
2'-fluoro substituted carba-nucleoside analogs for antiviral treatment
|
AU2010338011B2
(en)
|
2009-12-28 |
2015-04-02 |
Development Center For Biotechnology |
Novel pyrimidine compounds as mTOR and P13K inhibitors
|
US9198972B2
(en)
|
2010-01-28 |
2015-12-01 |
Alnylam Pharmaceuticals, Inc. |
Monomers and oligonucleotides comprising cycloaddition adduct(s)
|
WO2011123672A1
(en)
|
2010-03-31 |
2011-10-06 |
Pharmasset, Inc. |
Purine nucleoside phosphoramidate
|
HUE034239T2
(en)
|
2010-03-31 |
2018-02-28 |
Gilead Pharmasset Llc |
Method for Crystallization of (S) -isopropyl 2 - (((S) (perfluorophenoxy) (phenoxy) phosphoryl) amino) propanoate \ t
|
TW201201815A
(en)
|
2010-05-28 |
2012-01-16 |
Gilead Sciences Inc |
1'-substituted-carba-nucleoside prodrugs for antiviral treatment
|
EP2596004B1
(en)
|
2010-07-19 |
2014-09-10 |
Gilead Sciences, Inc. |
Methods for the preparation of diasteromerically pure phosphoramidate prodrugs
|
MX2013000744A
(es)
|
2010-07-22 |
2013-03-07 |
Gilead Sciences Inc |
Metodos y compuestos para tratar infecciones virales por paramyxoviridae.
|
TW201305185A
(zh)
|
2010-09-13 |
2013-02-01 |
Gilead Sciences Inc |
用於抗病毒治療之2’-氟取代之碳-核苷類似物
|
JP2013538230A
(ja)
|
2010-09-20 |
2013-10-10 |
ギリアード サイエンシーズ, インコーポレイテッド |
抗ウイルス治療用の2’−フルオロ置換カルバヌクレオシド類似体
|
CN103209987B
(zh)
|
2010-09-22 |
2017-06-06 |
艾丽奥斯生物制药有限公司 |
取代的核苷酸类似物
|
KR101850925B1
(ko)
|
2010-10-15 |
2018-04-20 |
바이오크리스트파마슈티컬즈,인코포레이티드 |
폴리머라아제 억제를 위한 방법 및 조성물
|
WO2012121764A1
(en)
|
2010-11-25 |
2012-09-13 |
Ratiopharm Gmbh |
Novel salts and polymorphic forms of afatinib
|
TW201701876A
(zh)
|
2010-12-20 |
2017-01-16 |
吉李德科學股份有限公司 |
治療c型肝炎病毒(hcv)之方法
|
AU2012242517B2
(en)
|
2011-04-13 |
2016-12-15 |
Gilead Sciences, Inc. |
1'-substituted pyrimidine N-nucleoside analogs for antiviral treatment
|
KR20140053906A
(ko)
|
2011-05-13 |
2014-05-08 |
조에티스 엘엘씨 |
헨드라 및 니파 바이러스 g 당단백질 면역원성 조성물
|
SG11201400664WA
(en)
|
2011-09-16 |
2014-04-28 |
Gilead Pharmassett Llc |
Methods for treating hcv
|
US8889159B2
(en)
|
2011-11-29 |
2014-11-18 |
Gilead Pharmasset Llc |
Compositions and methods for treating hepatitis C virus
|
WO2013084165A1
(en)
|
2011-12-05 |
2013-06-13 |
Medivir Ab |
Hcv polymerase inhibitors
|
US20130143835A1
(en)
|
2011-12-05 |
2013-06-06 |
Medivir Ab |
HCV Polymerase Inhibitors
|
EP2794630A4
(en)
|
2011-12-22 |
2015-04-01 |
Alios Biopharma Inc |
SUBSTITUTED PHOSPHORTHIOAT NUCLEOTIDE ANALOGUE
|
EP2852603B1
(en)
|
2012-05-22 |
2021-05-12 |
Idenix Pharmaceuticals LLC |
D-amino acid compounds for liver disease
|
WO2014033617A1
(en)
|
2012-08-31 |
2014-03-06 |
Novartis Ag |
2'-ethynyl nucleoside derivatives for treatment of viral infections
|
MA37942B1
(fr)
|
2012-09-10 |
2020-01-31 |
Hoffmann La Roche |
Hétéroaryldihydropyrimidines d'acide 6-aminé pour le traitement et la prophylaxie d'une infection par le virus de l'hépatite b
|
WO2014042433A2
(en)
|
2012-09-14 |
2014-03-20 |
Kainos Medicine, Inc. |
Compounds and compositions for modulating adenosine a3 receptor activity
|
WO2014078778A2
(en)
|
2012-11-16 |
2014-05-22 |
Biocryst Pharmaceuticals, Inc. |
Antiviral azasugar-containing nucleosides
|
WO2014078463A1
(en)
|
2012-11-19 |
2014-05-22 |
Merck Sharp & Dohme Corp. |
2 -alkynyl substituted nucleoside derivatives for treating viral diseases
|
SG11201504554UA
(en)
|
2012-12-21 |
2015-07-30 |
Alios Biopharma Inc |
Substituted nucleosides, nucleotides and analogs thereof
|
US9283242B2
(en)
|
2013-01-22 |
2016-03-15 |
Massachusetts Institute Of Technology |
Uses of dihydro bases
|
US10034893B2
(en)
|
2013-02-01 |
2018-07-31 |
Enanta Pharmaceuticals, Inc. |
5, 6-D2 uridine nucleoside/tide derivatives
|
BR112015025716A2
(pt)
|
2013-04-12 |
2017-07-18 |
Achillion Pharmaceuticals Inc |
pró-fármacos de nucleosídeo submetidos a deutério úteis para o tratamento de hcv
|
US9815864B2
(en)
|
2013-06-26 |
2017-11-14 |
Alios Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
UA117375C2
(uk)
|
2013-09-04 |
2018-07-25 |
Медівір Аб |
Інгібітори полімерази hcv
|
CN105764569B
(zh)
|
2013-09-11 |
2019-09-13 |
国家医疗保健研究所 |
治疗乙型肝炎病毒感染的方法和药物组合物
|
CA2927010C
(en)
|
2013-10-11 |
2022-06-07 |
Alios Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
UA119050C2
(uk)
|
2013-11-11 |
2019-04-25 |
Ґілеад Саєнсиз, Інк. |
ПІРОЛО[1.2-f][1.2.4]ТРИАЗИНИ, ЯКІ ВИКОРИСТОВУЮТЬСЯ ДЛЯ ЛІКУВАННЯ РЕСПІРАТОРНО-СИНЦИТІАЛЬНИХ ВІРУСНИХ ІНФЕКЦІЙ
|
EA201691261A1
(ru)
|
2014-01-30 |
2016-11-30 |
Ф. Хоффманн-Ля Рош Аг |
Новые дигидрохинолизиноны для лечения и профилактики инфекции, вызванной вирусом гепатита b
|
CR20160337A
(es)
|
2014-03-07 |
2016-09-20 |
Hoffmann La Roche |
Nuevas heteroarildihidropirimidinas 6-fusionadas para el tratamiento y la profilaxis de la infección por virus de la hepatitis b
|
CA2948080A1
(en)
|
2014-05-13 |
2015-11-19 |
F. Hoffmann-La Roche Ag |
Novel dihydroquinolizinones for the treatment and prophylaxis of hepatitis b virus infection
|
US9616076B2
(en)
|
2014-06-02 |
2017-04-11 |
The Board Of Regents Of The University Of Texas Systems |
Methods for treating viral infections using hydrogen sulfide donors
|
US9504701B2
(en)
|
2014-06-02 |
2016-11-29 |
The Board Of Regents Of The University Of Texas System |
Methods for treating viral infections using hydrogen sulfide donors
|
MX2016017381A
(es)
|
2014-06-24 |
2017-08-14 |
Alios Biopharma Inc |
Nucleosidos sustituidos, nucleotidos y analogos de los mismos.
|
AU2015280248B2
(en)
|
2014-06-24 |
2021-04-08 |
Alios Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
WO2016012470A1
(en)
|
2014-07-25 |
2016-01-28 |
F. Hoffmann-La Roche Ag |
New amorphous and crystalline forms of (3s)-4-[[(4r)-4-(2-chloro-4-fluoro-phenyl)-5-methoxycarbonyl-2-thiazol-2-yl-1, 4-dihydropyrimidin-6-yl]methyl]morpholine-3-carboxylic acid
|
JP6506836B2
(ja)
|
2014-08-14 |
2019-04-24 |
エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft |
B型肝炎ウイルス感染症の処置および予防のための新規ピリダゾンおよびトリアジノン
|
TWI740546B
(zh)
|
2014-10-29 |
2021-09-21 |
美商基利科學股份有限公司 |
製備核糖苷的方法
|
US9637485B2
(en)
|
2014-11-03 |
2017-05-02 |
Hoffmann-La Roche Inc. |
6,7-dihydrobenzo[a]quinolizin-2-one derivatives for the treatment and prophylaxis of hepatitis B virus infection
|
US9676793B2
(en)
|
2014-12-23 |
2017-06-13 |
Hoffmann-Laroche Inc. |
Co-crystals of 5-amino-2-oxothiazolo[4,5-d]pyrimidin-3(2H)-yl-5-hydroxymethyl tetrahydrofuran-3-yl acetate and methods for preparing and using the same
|
WO2016102438A1
(en)
|
2014-12-23 |
2016-06-30 |
F. Hoffmann-La Roche Ag |
Process for the preparation of 4-phenyl-5-alkoxycarbonyl-2-thiazol-2-yl-1,4-dihydropyrimidine analogues
|
JP6506845B2
(ja)
|
2014-12-30 |
2019-04-24 |
エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft |
B型肝炎ウイルス感染症の治療及び予防のための新規テトラヒドロピリドピリミジン類及びテトラヒドロピリドピリジン類
|
JP2018504891A
(ja)
|
2014-12-31 |
2018-02-22 |
エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft |
リアルタイムPCRによる細胞溶解物からのHBV cccDNA定量化のための新規ハイスループット法
|
MA41338B1
(fr)
|
2015-01-16 |
2019-07-31 |
Hoffmann La Roche |
Composés de pyrazine pour le traitement de maladies infectieuses
|
JP2018502604A
(ja)
|
2015-01-27 |
2018-02-01 |
エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft |
組換えHBV cccDNA、その作製方法およびその使用
|
EP3256471B1
(en)
|
2015-02-11 |
2018-12-12 |
F. Hoffmann-La Roche AG |
Novel 2-oxo-6,7-dihydrobenzo[a]quinolizine-3-carboxylic acid derivatives for the treatment and prophylaxis of hepatitis b virus infection
|
US10251904B2
(en)
|
2015-09-16 |
2019-04-09 |
Gilead Sciences, Inc. |
Methods for treating arenaviridae and coronaviridae virus infections
|
WO2017165489A1
(en)
|
2016-03-23 |
2017-09-28 |
Emory University |
Antiviral agents for treating zika and dengue virus infections
|
WO2017184668A1
(en)
|
2016-04-20 |
2017-10-26 |
Gilead Sciences, Inc. |
Methods for treating flaviviridae virus infections
|
JP7414525B2
(ja)
|
2016-11-03 |
2024-01-16 |
ウー,ローレンス,アイ. |
クロファラビンのプロドラッグ
|
CN108299532B
(zh)
|
2016-12-29 |
2020-12-22 |
广东东阳光药业有限公司 |
一种抗病毒核苷类似物前药及其组合物、用途
|
CN110325187B
(zh)
|
2017-02-08 |
2022-09-30 |
生物环境有限公司 |
N-氨基甲酰亚胺基-5-(1-甲基-1h-吡唑-4-基)-2-萘甲酰胺在制备治疗流感的药物中的用途
|
KR102318320B1
(ko)
|
2017-03-14 |
2021-10-27 |
길리애드 사이언시즈, 인코포레이티드 |
고양이 코로나바이러스 감염의 치료 방법
|
EP4219513A1
(en)
|
2017-05-01 |
2023-08-02 |
Gilead Sciences, Inc. |
Crystalline form of (s)-2-ethylbutyl 2-(((s)-(((2r,3s,4r,5r)-5-(4-aminopyrrolo[2,1-f] [1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran2-yl)methoxy)(phenoxy) phosphoryl)amino)propanoate
|
US11241491B2
(en)
|
2017-05-23 |
2022-02-08 |
The University Of North Carolina At Chapel Hill |
Methods and compositions for dengue virus serotype 4 epitopes
|
CA3077489A1
(en)
|
2017-07-11 |
2019-01-17 |
Gilead Sciences, Inc. |
Compositions comprising an rna polymerase inhibitor and cyclodextrin for treating viral infections
|
US20190023745A1
(en)
|
2017-07-19 |
2019-01-24 |
The University Of North Carolina At Chapel Hill |
Methods and compositions for zika virus vaccines
|
WO2019053696A1
(en)
*
|
2017-09-18 |
2019-03-21 |
Alios Biopharma, Inc. |
SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF
|
WO2019079594A1
(en)
|
2017-10-18 |
2019-04-25 |
The University Of North Carolina At Chapel Hill |
METHODS AND COMPOSITIONS FOR VACCINES AGAINST NOVOVIRUS AND DIAGNOSIS OF NOVOVIRUS
|
WO2021021717A1
(en)
|
2019-07-27 |
2021-02-04 |
Brii Biosciences, Inc. |
Adenosine derivative and pharmaceutical composition comprising the same
|
CN110330540A
(zh)
|
2019-08-08 |
2019-10-15 |
木天(济南)生物科技有限公司 |
核苷盐及其制备方法
|
WO2021040356A1
(en)
|
2019-08-23 |
2021-03-04 |
Kainos Medicine, Inc. |
C-nucleosides, c-nucleotides and their analogs, equivalents and prodrugs thereof for ectonucleotidase inhibition
|
CR20220110A
(es)
|
2019-09-11 |
2022-06-16 |
Scripps Research Inst |
Profármacos antivirales y composiciones farmacéuticas de los mismos
|
WO2021102363A1
(en)
|
2019-11-20 |
2021-05-27 |
The University Of North Carolina At Chapel Hill |
Methods and compositions for recombinant dengue viruses for vaccine and diagnostic development
|
CN110776512A
(zh)
|
2019-11-28 |
2020-02-11 |
成都傲飞生物化学品有限责任公司 |
一种核苷类似物的制备方法
|
CN111265532A
(zh)
|
2020-01-21 |
2020-06-12 |
中国人民解放军军事科学院军事医学研究院 |
取代氨基丙酸酯类化合物在治疗2019-nCoV感染中的应用
|
US20230078330A1
(en)
|
2020-01-27 |
2023-03-16 |
Vanderbilt University |
Human anti-dengue antibodies and methods of use therefor
|
TWI789695B
(zh)
|
2020-01-27 |
2023-01-11 |
美商基利科學股份有限公司 |
治療sars cov-2感染之方法
|
CN113248508A
(zh)
|
2020-02-13 |
2021-08-13 |
安徽诺全药业有限公司 |
N-保护的杂环类化合物、其制备方法及其用于制备c-核苷衍生物的方法
|
CN111205327B
(zh)
|
2020-02-17 |
2022-05-31 |
南京法恩化学有限公司 |
一种瑞德西韦的制备方法
|
TW202315607A
(zh)
|
2020-02-18 |
2023-04-16 |
美商基利科學股份有限公司 |
抗病毒化合物
|
CN113292565B
(zh)
|
2020-02-24 |
2023-01-31 |
浙江森科建设有限公司 |
核苷类化合物及其制备方法和应用
|
CN111205294B
(zh)
|
2020-02-27 |
2021-10-01 |
江苏阿尔法药业股份有限公司 |
一种瑞德西韦中间体的制备方法
|
CN111171078B
(zh)
*
|
2020-02-27 |
2022-04-22 |
江苏阿尔法药业股份有限公司 |
一种瑞德西韦的合成方法
|
WO2021175296A1
(zh)
|
2020-03-04 |
2021-09-10 |
中国科学院上海药物研究所 |
瑞德西韦的中间体及其制备方法
|
CN113387954B
(zh)
|
2020-03-11 |
2024-03-19 |
上海特化医药科技有限公司 |
一种瑞德西韦中间体的制备方法
|
CN115298181A
(zh)
|
2020-03-12 |
2022-11-04 |
吉利德科学公司 |
制备1’-氰基核苷的方法
|
CN111233869B
(zh)
|
2020-03-12 |
2022-09-16 |
杭州新博思生物医药有限公司 |
用于制备瑞德西韦关键中间体的新化合物及其制备方法
|
US20230137667A1
(en)
|
2020-03-19 |
2023-05-04 |
The University Of North Carolina At Chapel Hill |
Methods and compositions for treatment of coronavirus infection
|
AU2021244718A1
(en)
|
2020-03-23 |
2022-11-03 |
John M.H. GREGG |
Anti-viral compounds and methods for administration thereof
|
CN111548384B
(zh)
|
2020-03-29 |
2021-04-27 |
常州安蒂卫生物科技有限公司 |
用于抗病毒治疗的被取代的n4-羟基胞苷衍生物及其前药
|
WO2021202907A2
(en)
|
2020-04-02 |
2021-10-07 |
The Regents Of The University Of Michigan |
Remdesivir and remdesivir analogs, solutions, and nanoparticle, liposomal, and microparticle compositions for treating viral infections
|
WO2021207049A1
(en)
|
2020-04-06 |
2021-10-14 |
Gilead Sciences, Inc. |
Inhalation formulations of 1'-cyano substituted carbanucleoside analogs
|
CN112778310A
(zh)
|
2020-04-20 |
2021-05-11 |
中国科学院上海药物研究所 |
核苷类似物或含有核苷类似物的组合制剂在抗病毒中的应用
|
CN111440176B
(zh)
|
2020-04-28 |
2022-04-26 |
江苏大学 |
金属配合物促进的瑞德西韦中间体的合成方法
|
WO2021222807A1
(en)
|
2020-04-30 |
2021-11-04 |
Ajk Pharmaceutical Llc |
Fatty acyl and fatty ether conjugates of remdesivir and its active metabolites as antivirals
|
CN111961057A
(zh)
|
2020-05-26 |
2020-11-20 |
李小冬 |
一种α构型核苷及其在治疗猫冠状病毒感染的应用
|
KR20230018473A
(ko)
|
2020-05-29 |
2023-02-07 |
길리애드 사이언시즈, 인코포레이티드 |
렘데시비르 치료 방법
|
US11377456B2
(en)
*
|
2020-06-11 |
2022-07-05 |
Apotex Inc. |
Crystalline form of Remdesivir
|
IL299202A
(en)
|
2020-06-24 |
2023-02-01 |
Gilead Sciences Inc |
1'-cyano nucleoside analogs and uses thereof
|
WO2022008642A1
(en)
|
2020-07-08 |
2022-01-13 |
Apeiron Biologics Ag |
Treatment of sars-cov-2 infection with a combination of targets
|
CA3185450A1
(en)
|
2020-08-06 |
2022-02-10 |
Istvan Borza |
Remdesivir intermediates
|
EP4204421A2
(en)
|
2020-08-27 |
2023-07-05 |
Gilead Sciences, Inc. |
Compounds and methods for treatment of viral infections
|
CA3193447A1
(en)
|
2020-08-28 |
2022-03-03 |
Sayvaa Pharmaceuticals Inc. |
Formulations of anti-viral compounds
|
US11225508B1
(en)
|
2020-09-23 |
2022-01-18 |
The University Of North Carolina At Chapel Hill |
Mouse-adapted SARS-CoV-2 viruses and methods of use thereof
|
WO2022081870A1
(en)
|
2020-10-14 |
2022-04-21 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Stabilized norovirus virus-like particles as vaccine immunogens
|
WO2022093895A1
(en)
|
2020-10-27 |
2022-05-05 |
The University Of North Carolina At Chapel Hill |
Chimeric coronavirus s protein compositions and methods of use
|
WO2022098371A1
(en)
|
2020-11-09 |
2022-05-12 |
Yan Matthew |
Prodrugs of 1'-substituted carba-nucleoside analogues for antiviral treatment
|
CN114621229A
(zh)
|
2020-12-11 |
2022-06-14 |
嘉兴金派特生物科技有限公司 |
治疗或预防猫传染性腹膜炎的化合物或组合物
|
CN113735862B
(zh)
|
2020-12-30 |
2024-02-02 |
南方科技大学 |
一种治疗病毒感染的核苷类化合物及其用途
|
CN113754665B
(zh)
|
2020-12-30 |
2022-08-19 |
南方科技大学 |
一种核苷类化合物的制备方法
|
WO2022165386A1
(en)
|
2021-01-29 |
2022-08-04 |
Virbis Llc |
Lnp and lmp delivery of antiviral nucleotide 5'-phosphates
|
WO2022174194A1
(en)
|
2021-02-15 |
2022-08-18 |
Emory University |
4'-halogen containing nucleotide and nucleoside therapeutic compositions and uses related thereto
|
WO2022197950A1
(en)
|
2021-03-17 |
2022-09-22 |
The University Of North Carolina At Chapel Hill |
Methods and compositions for mature dengue viruses as vaccines and diagnostics
|
AU2022254108A1
(en)
|
2021-04-09 |
2023-10-26 |
Emory University |
Nucleosides and nucleotides analogs as antiviral agents
|
WO2022218274A1
(zh)
|
2021-04-15 |
2022-10-20 |
中国科学院上海药物研究所 |
核苷类似物及其用途
|
CN113185519A
(zh)
|
2021-04-23 |
2021-07-30 |
苏州富德兆丰生化科技有限公司 |
一种核苷类化合物及其在治疗猫传染性腹膜炎中的应用
|
JP2024515140A
(ja)
|
2021-04-23 |
2024-04-04 |
ヴィゴンヴィータ ライフ サイエンシス カンパニー リミテッド |
ヌクレオシド系化合物及び猫伝染性腹膜炎の治療におけるその使用
|
WO2022251663A2
(en)
|
2021-05-27 |
2022-12-01 |
Emory University |
Novel universal anti-rna virus agents
|
CN113698405B
(zh)
|
2021-06-03 |
2022-09-27 |
南方科技大学坪山生物医药研究院 |
一种核苷类化合物的晶型及其制备方法
|
WO2022265964A1
(en)
|
2021-06-14 |
2022-12-22 |
VenatoRx Pharmaceuticals, Inc. |
Orally-bioavailable nucleoside analogs
|
WO2023009977A1
(en)
|
2021-07-26 |
2023-02-02 |
The University Of North Carolina At Chapel Hill |
Methods and compositions for norovirus chimeric therapeutics
|
IL310854A
(en)
|
2021-08-20 |
2024-04-01 |
Shionogi & Co |
Nucleoside compounds and their drug derivatives possessing viral growth inhibitory activity
|
US11541071B1
(en)
|
2021-12-16 |
2023-01-03 |
Ascletis BioScience Co., Ltd |
Nucleoside derivatives and methods of use thereof
|
CN114409655A
(zh)
|
2022-01-26 |
2022-04-29 |
郑州大学 |
3′,4′-不饱和核糖c-核苷类似物及其制备方法
|
CN114437159B
(zh)
|
2022-04-11 |
2022-06-28 |
佛山市晨康生物科技有限公司 |
一种环状碳酸酯核苷类化合物及其应用
|
CN115521316A
(zh)
|
2022-09-23 |
2022-12-27 |
深圳安泰维生物医药有限公司 |
一种核苷类化合物或其中间体的制备方法和核苷类化合物的中间体
|